Program to improve lifestyle for breast cancer patients
Reborn Lifestyle Adjustment Program for Breast Cancer Patients
This study tests whether a lifestyle program can help breast cancer patients feel better and improve their overall health while they receive regular therapy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Atlas University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06608043 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the effects of the Reborn Lifestyle Adjustment Program on various health aspects in breast cancer patients, including physical activity, fatigue, pain, mental health, and overall quality of life. Participants will engage in the program alongside conventional physiotherapy and occupational therapy. The study aims to assess how lifestyle adjustments can enhance recovery and well-being in individuals diagnosed with Stage I, II, or III breast cancer.
Who should consider this trial
Good fit: Ideal candidates are female individuals aged 18 or older who have been diagnosed with Stage I, II, or III breast cancer and have completed chemotherapy at least 6 months prior.
Not a fit: Patients with neurological or systemic diseases, metastasis, or those who have recently participated in a healthy lifestyle program may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and mental health of breast cancer patients post-treatment.
How similar studies have performed: While similar lifestyle adjustment programs have shown promise in improving patient outcomes, this specific approach is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being a female individual aged 18 or older * Have been diagnosed with Stage I, II, or III breast cancer * At least 6 months have passed since the completion of chemotherapy * Approval by an oncologist to participate in the study * Having internet access and the ability to connect online * Scoring above 23 on a standardized Mini Mental Status Examination Test * Being in the contemplation stage according to the Transtheoretical Model Exclusion Criteria: * Having a neurological or systemic disease that could significantly affect the course of the intervention * Having metastasis that could impact the sustainability of the study * Suffering from neuropathic pain * Having participated in a healthy lifestyle program within the last 3 months
Where this trial is running
Istanbul
- Istanbul Atlas University — Istanbul, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Sena Ondes, MSc
- Email: senaaondes@gmail.com
- Phone: +905387094535
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.